CRIS Current Research Information System

LAURIOLA, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.061
NA - Nord America 5.046
EU - Europa 4.315
Continente sconosciuto - Info sul continente non disponibili 408
SA - Sud America 305
AF - Africa 266
OC - Oceania 18
Totale 15.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.922
IT - Italia 1.928
SG - Singapore 1.420
CN - Cina 1.333
VN - Vietnam 1.139
GB - Regno Unito 518
DE - Germania 429
HK - Hong Kong 307
SE - Svezia 297
BR - Brasile 240
FR - Francia 214
IN - India 174
KR - Corea 162
NL - Olanda 152
IE - Irlanda 142
RU - Federazione Russa 119
AT - Austria 111
FI - Finlandia 111
BD - Bangladesh 110
JP - Giappone 92
CI - Costa d'Avorio 89
CA - Canada 71
ZA - Sudafrica 64
UA - Ucraina 57
TG - Togo 56
ID - Indonesia 46
JO - Giordania 45
BG - Bulgaria 40
EE - Estonia 40
TH - Thailandia 35
CH - Svizzera 34
PH - Filippine 33
AR - Argentina 31
MY - Malesia 25
ES - Italia 24
SC - Seychelles 24
PL - Polonia 22
TW - Taiwan 18
AU - Australia 16
IL - Israele 16
IQ - Iraq 16
TR - Turchia 16
PK - Pakistan 15
GR - Grecia 14
IR - Iran 14
MX - Messico 14
DK - Danimarca 11
SA - Arabia Saudita 11
EC - Ecuador 10
JM - Giamaica 10
CR - Costa Rica 9
RO - Romania 9
UZ - Uzbekistan 9
BE - Belgio 8
MA - Marocco 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
CO - Colombia 6
LT - Lituania 6
GT - Guatemala 5
HR - Croazia 5
NG - Nigeria 5
VE - Venezuela 5
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
PE - Perù 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CL - Cile 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
JE - Jersey 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
Totale 15.006
Salva come PNG Salva come JPEG
Città #
Singapore 999
Bologna 753
Ashburn 600
Southend 415
Chandler 354
Fairfield 324
Hefei 323
Hong Kong 277
San Jose 276
Ho Chi Minh City 267
Hanoi 253
Houston 237
Santa Clara 185
Seattle 178
Woodbridge 162
Council Bluffs 146
Dublin 139
Seoul 137
Boardman 136
Wilmington 135
Milan 130
Beijing 125
Cambridge 122
Princeton 117
Dallas 111
Vienna 100
Abidjan 89
Lauterbourg 89
New York 80
Dong Ket 79
Los Angeles 79
Helsinki 77
Ann Arbor 76
São Paulo 73
Tokyo 73
Redmond 62
Bremen 58
Nanjing 58
Lomé 56
Rome 51
Berlin 48
Westminster 46
Amman 45
Buffalo 44
Naples 43
Bar Harbor 42
Da Nang 41
Sofia 40
Munich 39
Frankfurt am Main 38
Haiphong 38
Jakarta 37
Modena 37
Amsterdam 36
Shanghai 35
Padova 34
Bengaluru 31
Florence 29
London 29
Chicago 28
Guangzhou 26
Nuremberg 26
Bern 25
Jinan 25
Saint Petersburg 25
Turin 25
Redondo Beach 24
Shenyang 24
Rimini 22
The Dalles 22
Montreal 21
Orem 21
San Lazzaro di Savena 21
Medford 20
San Diego 20
Reggio Emilia 19
Lappeenranta 18
Bangkok 17
Jiaxing 17
Boydton 16
Changsha 16
Hải Dương 16
Jacksonville 16
Can Tho 15
Falkenstein 15
Phoenix 15
San Francisco 15
Turku 15
Zhengzhou 15
Atlanta 14
Tianjin 14
Toronto 14
Brescia 13
Brooklyn 13
Düsseldorf 13
Forlì 13
Kuala Lumpur 13
Olalla 13
Rehovot 13
Thái Nguyên 13
Totale 9.479
Salva come PNG Salva come JPEG
Nome #
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration 433
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 318
EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer 279
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 273
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects 254
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5-methyl-tetrahydrofolate and 5-formyl-tetrahydrofolate 242
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 241
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer 238
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 236
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 227
IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. 227
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 224
A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. 223
Submicroscopic alterations and gene expression profiles of human colon cancer cell lines in response to cetuximab, gefitinib and EGF 221
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 220
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 219
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 216
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 213
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 212
Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood 212
Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. 212
The EGFR R521K polymorphism influences the risk to develop colorectal cancer. 208
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection 208
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 208
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 206
Modulation of ERBB signaling from tissue homeostasis to cancer progression 205
Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. 204
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 201
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 198
Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant. 197
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 192
ERBB2 circumvents negative feedback mechanisms induced by EGFR overactivation in basal-like/triple-negative breast cancer cells 191
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 190
The roadmap of colorectal cancer screening 188
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 187
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection 185
Fibroblast-associated protein-α expression and BPV nucleic acid distribution in equine sarcoids 178
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 177
Estrogen Receptors and Melanoma: A Review 175
A putative role for interleukin 1 pathway in resistance to EGFR blockade 173
Resistance to EGFR Targeting Treatments in Colorectal Cancer 171
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 170
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor 168
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 167
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 167
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 165
The R521K polymorphism of EGFR influences the risk of colorectal cancer 162
An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors 161
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 155
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 149
Identification of novel growth factors for cardiac regeneration 147
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 147
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 145
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 142
Female melanoma and estrogen receptors expression: an immunohistochemical pilot study 138
qCMA: A Desktop Application for Quantitative Collective Cell Migration Analysis 136
null 136
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 136
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 136
Unveiling the role of interleukine-1 Receptor in response to EGFR blockade 133
null 128
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 125
A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib 124
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors 122
null 121
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers 117
null 117
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions 116
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways 115
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 115
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals 115
Modeling ductal carcinoma in situ: a HER2–Notch3 collaboration enables luminal filling 113
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result 108
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 108
Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. 108
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 106
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 104
ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation 104
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 96
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 95
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 95
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening Programmes 93
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 91
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer 90
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 87
null 87
null 82
null 81
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 79
null 74
null 72
Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression 62
Harnessing glucocorticoid receptor antagonism to enhance the efficacy of cardiac regenerative growth factors and cytokines 61
Circadian dependent motility: the role for the perinuclear actin cap 61
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 50
Sorcin regulates alveolarization and airway tissue remodeling during lung morphogenesis 49
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 36
Towards the emerging crosstalk: ERBB family and steroid hormones 34
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 26
Structure-guided identification of small molecules potentially able to modulate GDF15 activity 10
Totale 15.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.383
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.073 0 38 60 57 88 64 32 81 74 81 250 248
2022/20231.788 142 220 101 253 147 135 79 130 306 49 105 121
2023/2024752 59 93 40 75 60 144 40 46 25 75 41 54
2024/20252.582 104 235 225 181 281 147 295 143 85 209 235 442
2025/20266.061 469 584 526 428 516 367 625 198 1.215 490 318 325
2026/2027489 261 228 0 0 0 0 0 0 0 0 0 0
Totale 15.419